IN Brief:
- Kerry reported Q3 volume growth of 4.1%, compared with 3.6% for the first nine months of 2026.
- Europe grew 1.3% by volume in Q3, against 4.6% in the Americas and 5.7% in APMEA.
- The company reported a 50-basis-point year-to-date EBITDA margin expansion, supported mainly by Accelerate 2.0.
Kerry Group reported third-quarter 2026 volume growth of 4.1%, supported by food manufacturers reformulating products and developing new taste, nutrition and preservation applications. The Irish ingredients company said its Accelerate 2.0 programme continued to improve margins alongside investment in taste and biotechnology capabilities across its operating regions.
The third-quarter figure marks an acceleration from the 3.6% volume growth recorded over the first nine months. Pricing declined 0.6% over the nine-month period but increased 0.2% during the latest quarter, as earlier input cost deflation gave way to inflation. Kerry reported a 0.6% fall in year-to-date revenue after taking account of pricing, foreign exchange and portfolio changes.
An adverse currency translation effect of 2.5% contributed to that reported revenue movement, principally reflecting weakness in the US dollar against the euro. A further 0.2% adverse transaction currency effect and a 0.9% net reduction from disposals and acquisitions also affected the calculation. Those factors explain why higher physical sales volumes did not produce an equivalent increase in reported sales.
Demand was strongest across snacks, meat, dairy and beverage end-use markets. Kerry supplies manufacturers with taste systems, nutritional ingredients, enzymes and fermentation-based preservation technologies. Its customers use these ingredients in new products and when changing an established formulation to address flavour, nutrition, cost or supply requirements.
In Europe, volumes rose 1.3% during the third quarter and 0.7% over the first nine months. Kerry identified good activity in beverages, including low and no alcohol drinks using botanicals and sugar reduction technology, as well as savoury snack systems and protein masking for dairy. Meals and bakery remained affected by weaker category volumes, so regional growth was not uniform across applications.
The group is expanding its proactive health manufacturing capacity and capabilities in Spain. The update identifies that regional investment but gives no plant-specific construction cost, new production tonnage or commissioning timetable. It should not be taken as evidence of a completed production line or of increased output already realised at a named Spanish facility.
Volume growth in the Americas reached 4.6% in Q3, compared with 4.0% for the nine-month period. North American snack applications benefited from savoury taste profiles and salt reduction work, while beverages drew on botanicals, natural extracts and sugar reduction systems. Kerry also cited nutritional drinks requiring protein masking and poultry products incorporating taste and preservation technologies.
The company reported investment in beverage taste capabilities in North America and progress in expanding its savoury taste footprint in Mexico. These developments form part of a strategy to serve customer formulation activity through regional production and technical expertise. The statement does not break down the additional capacity or provide individual investment budgets.
Across Asia Pacific, the Middle East and Africa, Q3 volume growth was 5.7% and the nine-month increase was 5.2%. Dairy enzymes and taste systems contributed, alongside meat texture solutions, savoury snack ingredients and bakery formulations. Kerry also reported starting a local taste footprint expansion in Türkiye and further expansion in the Middle East.
Formulation work can involve competing technical requirements. Reducing sugar changes sweetness intensity and can alter the balance of flavour in a beverage. Protein enrichment can introduce flavour notes that require masking, while changing a preservation system may affect both the intended shelf life and sensory properties. Kerry describes integrated solutions spanning those functions rather than sales of a single ingredient in isolation.
Actual performance in a finished food depends on the recipe, processing conditions and ingredient interactions. Kerry’s trading update reports customer demand for its technologies but does not quantify how many reformulated products were launched or what percentage reduction in sugar, salt or spoilage was achieved through particular applications. Those outcomes require product-specific evidence.
Foodservice volumes increased 5.0% during the first nine months, supported by menu development, seasonal products and work intended to simplify kitchen operations. The retailer channel also contributed through product renovation and innovation. These routes to market involve different development cycles, but both generate demand for repeatable ingredients that can meet the specifications of multiple customer sites.
Kerry reported a 50-basis-point expansion in its EBITDA margin for the first nine months, primarily driven by Accelerate 2.0. The programme includes manufacturing footprint optimisation in Europe and North America and the deployment of digital initiatives across factories, commercial operations and shared services. Operating leverage, product mix, pricing and portfolio changes also contributed, while increased research spending and currency movements partly offset the benefits.
The company has not assigned the margin improvement to specific factory closures, software installations or equipment projects in this statement. Its manufacturing and digital activity therefore provides a credible operational context for the results, but not a basis for calculating savings at individual production sites.
At the end of September, net debt stood at €2.4 billion. Kerry maintained guidance for constant-currency adjusted earnings per share growth of 6% to 10% in 2026 and outlined an intention to begin a further share buyback of up to €300 million once the existing programme concludes. Its next trading updates will show whether stronger third-quarter demand can be sustained alongside the regional capacity and operational programmes already under way.
